Organization
University of Brescia
5 abstracts
Abstract
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma (OPC) treated with intensity modulated radiation therapy (IMRT) ± systemic therapy (ST).Org: UO Oncologia Medica 2, University of Brescia, Radiation Oncology Policlinico San Martino IRCCS, Cruces University Hospital, Radiotherapists Unit,
Abstract
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety.Org: University of Brescia, ASST Spedali Civili - Brescia, Angelo Nocivelli Institute of Molecular Medicine, University of Brescia and ASST-Spedali Civili, ASST-Spedali Civili of Brescia,
Abstract
Profile of toxicities and quality of life in long-term survivors treated with immunotherapy: A prospective cross sectional trial.Org: University of Brescia, ASST Spedali Civili - Brescia, University Hospital of Parma, University of Pisa, Pisa, Italy, ATC Innovation Lab,
Abstract
NEO-CESQ study: Neoadjuvant plus adjuvant treatment with cemiplimab in surgically resectable, high risk stage III/IV (M0) cutaneous squamous cell carcinoma.Org: Melanoma and Sarcoma Medical Oncology Unit, Sun Yat-sen University Cancer Center, Guangzhou, China, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Medical Oncology Unit, Ramazzini Hospital, Carpi, Italy, Department of Medical and Surgical Specialties,
Abstract
ANTI-TH/TO POSITIVITY IN SYSTEMIC SCLEROSIS: ANALYSIS OF PULMONARY INVOLVEMENT, ORGAN DAMAGE ACCRUAL AND MORTALITY IN AN ITALIAN MONOCENTRIC COHORTOrg: ASST Spedali Civili - Brescia, University of Brescia, Rheumatology and Clinical Immunology, Biomedical Engineering, Vascular diseases, University Medical Center, Groningen, Netherlands,